Fleming, R A <br/><br/>
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 1996 
 - 1107-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Aspartate Carbamoyltransferase--antagonists & inhibitors<br/>Aspartic Acid--administration & dosage<br/>Dipyridamole--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leukocytes--enzymology<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Phosphonoacetic Acid--administration & dosage<br/>Uridine Triphosphate--metabolism